Kwality Pharma

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE552U01010
  • NSEID: KPL
  • BSEID: 539997
INR
3,752.10
-84.8 (-2.21%)
BSENSE

Sep 22, 03:30 PM

BSE+NSE Vol: 60.58 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Cr
Consolidated - Balance Sheet Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
EQUITY AND LIABILITIES
No of Months
12
12
12
12
12
12
Share Capital
10.38
10.38
10.38
10.38
10.38
10.38
Share Warrants & Outstandings
Total Reserve
321.22
253.67
213.84
190.14
170.77
50.78
Shareholder's Funds
331.60
264.05
224.21
200.52
181.14
61.15
Minority Interest
-1.67
-1.65
-1.63
-1.45
-1.35
0.00
Long-Term Borrowings
29.40
15.12
19.56
27.30
20.29
18.26
Secured Loans
29.40
15.12
19.56
27.19
19.59
16.26
Unsecured Loans
0.00
0.00
0.00
0.12
0.70
2.00
Deferred Tax Assets / Liabilities
-2.50
-1.61
-0.03
0.41
0.27
-0.04
Other Long Term Liabilities
6.18
0
0
0
0
9.86
Long Term Trade Payables
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
1.18
0.25
0.22
0.90
0.75
0.00
Total Non-Current Liabilities
34.27
13.76
19.75
28.62
21.32
28.08
Current Liabilities
Trade Payables
101.69
55.79
44.32
35.19
34.51
26.21
Other Current Liabilities
22.38
16.22
28.89
27.79
71.25
35.62
Short Term Borrowings
101.06
97.33
78.56
62.96
33.72
16.45
Short Term Provisions
0.39
0.16
0.08
0.00
0.00
0.00
Total Current Liabilities
225.52
169.50
151.85
125.95
139.49
78.29
Total Liabilities
589.71
445.66
394.18
353.63
340.59
166.23
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
Gross Block
261.26
231.57
206.64
170.15
128.13
82.22
Less: Accumulated Depreciation
105.68
85.87
67.58
49.66
36.39
25.69
Less : Impairment of Assets
0.00
0.00
0.00
0.00
0.00
0.00
Net Block
155.57
145.69
139.05
120.50
91.73
56.53
Lease Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Capital Work in Progress
17.01
0.00
0.00
14.29
12.15
2.89
Intangible assets under development
0.00
0.00
0.00
0.00
0.00
0.00
Pre-operative Expenses pending
0.00
0.00
0.00
0.00
0.00
0.00
Assets in transit
0.00
0.00
0.00
0.00
0.00
0.00
Non Current Investments
0.00
0.00
0.00
0.00
0.00
0.73
Long Term Loans & Advances
10.13
11.53
11.38
10.84
8.43
0.17
Other Non Current Assets
1.32
4.66
1.07
0.81
0.46
0.00
Total Non-Current Assets
184.03
161.88
151.49
146.43
112.77
60.33
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00
0.00
4.44
Inventories
78.25
83.47
78.39
86.31
53.36
17.36
Sundry Debtors
280.05
154.31
114.39
71.69
69.13
35.71
Cash and Bank
3.59
14.76
5.94
7.36
12.95
5.81
Other Current Assets
8.52
12.79
9.36
6.90
8.80
0.00
Short Term Loans and Advances
35.26
18.46
34.61
34.93
83.58
42.58
Total Current Assets
405.68
283.78
242.69
207.20
227.82
105.90
Net Current Assets (Including Current Investments)
180.16
114.27
90.84
81.25
88.33
27.61
Total Current Assets Excluding Current Investments
405.68
283.78
242.69
207.20
227.82
101.46
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00
0.00
0.00
Total Assets
589.71
445.66
394.18
353.63
340.59
166.23
Contingent Liabilities
36.98
36.98
0.35
0.51
0.05
0.59
Total Debt
130.46
112.45
98.12
90.26
54.01
34.72
Book Value per share (adjusted)
318.8
253.7
215.31
192.48
173.81
58.16
Balance Sheet Analysis Highlights
stock-summary

Borrowings

YoY Growth in year ended Mar 2026 is 16.02% vs 14.60% in Mar 2025

stock-summary

Other Long Term Liabilities

No Other Long Term Liabilities in the last few periods;

stock-summary

Fixed Assets

YoY Growth in year ended Mar 2026 is 18.46% vs 4.78% in Mar 2025

stock-summary

Investments

No Investments in the last few periods;

stock-summary

Current Assets

YoY Growth in year ended Mar 2026 is 42.96% vs 16.93% in Mar 2025

Compare Balance Sheet Results of Kwality Pharma
Markets Mojo
Figures in Cr
Consolidated - Balance Sheet Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
10.38
8.87
1.51
17.02%
Share Warrants & Outstandings
Total Reserve
321.22
614.90
-293.68
-47.76%
Shareholder's Funds
331.60
639.64
-308.04
-48.16%
Minority Interest
-1.67
0.00
-1.67
0.00%
Long-Term Borrowings
29.40
139.36
-109.96
-78.90%
Secured Loans
29.40
138.16
-108.76
-78.72%
Unsecured Loans
0.00
1.20
-1.20
-100.00%
Deferred Tax Assets / Liabilities
-2.50
48.10
-50.60
-105.20%
Other Long Term Liabilities
6.18
0.00
6.18
0.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
1.18
1.21
-0.03
-2.48%
Total Non-Current Liabilities
34.27
188.67
-154.40
-81.84%
Current Liabilities
Trade Payables
101.69
113.92
-12.23
-10.74%
Other Current Liabilities
22.38
37.95
-15.57
-41.03%
Short Term Borrowings
101.06
171.39
-70.33
-41.04%
Short Term Provisions
0.39
1.11
-0.72
-64.86%
Total Current Liabilities
225.52
324.37
-98.85
-30.47%
Total Liabilities
589.71
1,152.68
-562.97
-48.84%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
261.26
759.92
-498.66
-65.62%
Less: Accumulated Depreciation
105.68
226.94
-121.26
-53.43%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
155.57
532.98
-377.41
-70.81%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
17.01
34.67
-17.66
-50.94%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.00
11.68
-11.68
-100.00%
Long Term Loans & Advances
10.13
15.94
-5.81
-36.45%
Other Non Current Assets
1.32
2.95
-1.63
-55.25%
Total Non-Current Assets
184.03
598.21
-414.18
-69.24%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
78.25
284.73
-206.48
-72.52%
Sundry Debtors
280.05
203.23
76.82
37.80%
Cash and Bank
3.59
41.59
-38.00
-91.37%
Other Current Assets
8.52
22.23
-13.71
-61.67%
Short Term Loans and Advances
35.26
2.69
32.57
1,210.78%
Total Current Assets
405.68
554.47
-148.79
-26.83%
Net Current Assets (Including Current Investments)
180.16
230.10
-49.94
-21.70%
Total Current Assets Excluding Current Investments
405.68
554.47
-148.79
-26.83%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
589.71
1,152.68
-562.97
-48.84%
Contingent Liabilities
36.98
11.00
25.98
236.18%
Total Debt
130.46
310.76
-180.30
-58.02%
Book Value per share (adjusted)
318.80
70.36
248.44
353.10%
Annual - Borrowings
Borrowings 130.46 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 16.02% vs 14.60% in Mar 2025

Annual - Other Long Term Liabilities
Other Long Term Liabilities 6.18 Cr
in Mar 2026

Figures in Cr
stock-summary

No Other Long Term Liabilities in the last few periods;

Annual - Fixed Assets
Fixed Assets 172.58 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 18.46% vs 4.78% in Mar 2025

Annual - Investments
Markets Mojo
No Investments in the last few periods
stock-summary

No Investments in the last few periods;

Annual - Current Assets
Current Assets 405.68 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 42.96% vs 16.93% in Mar 2025